Meet This BioPharma Company With Several Exciting Drugs In Advanced Clinical Trials

Sign up for this week’s All Access giveaway here! 

Pnina Fishman, Ph.D., CEO of Can-Fite BioPharma (NYSE: CANF), was a guest on Benzinga’s All Access on Nov 4, 2022.

Can-Fite is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The Company has an advanced pipeline of proprietary drug candidates in Phase II and Phase III clinical development which address inflammatory, liver and metabolic diseases.

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.